Thalidomide in refractory vulvar ulcerations associated with Crohn's disease

Dermatology. 2003;206(4):381-3. doi: 10.1159/000069963.

Abstract

We report a case of recurrent vulvar ulcerations developed on vegetations associated with Crohn's disease. Lesions responded to low-dose thalidomide treatment. A biopsy revealed a neutrophilic infiltrate with rare giant cells. Vulvar manifestations were consistent with metastatic Crohn's disease or with a reactive neutrophilic dermatitis. Thalidomide reduces the activity of tumor necrosis factor (TNF) alpha by accelerating the degradation of its mRNA. Nowadays, it has become a promising drug in a broad variety of disorders in which TNF-alpha seems to play a pivotal role, including inflammatory bowel diseases. This is the first case report presenting the efficacy of thalidomide in the treatment of vulvar involvement in Crohn's disease.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Crohn Disease / complications
  • Crohn Disease / drug therapy*
  • Female
  • Humans
  • Immunosuppressive Agents / therapeutic use*
  • Thalidomide / therapeutic use*
  • Treatment Outcome
  • Ulcer / drug therapy*
  • Ulcer / etiology
  • Vulvar Diseases / drug therapy*
  • Vulvar Diseases / etiology

Substances

  • Immunosuppressive Agents
  • Thalidomide